Type 2 diabetes trials in Belgium

In Belgium 22 Also abroad 1200

22 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Where
Aalst, Anderlecht, Leuven, Liège, Roeselare
Age
18 years and over
People
2,000 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07351045 · EU 2025-523104-71-00
No phaseTaking people
Real-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs)
Where
Leuven
People
60 worldwide
Run by
Sanofi
See details and how to joinNCT07457580
Phase 3Taking people
A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes
Where
Brussels, Gent, Leuven
Age
10 years to 17 years
People
170 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07668336 · EU 2025-524811-35-00
Phase 3Taking people
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Where
Brussels, Bruxelles-Capitale, Genk, Ieper, Kortrijk, Leuven, Mechelen, Ostend, Putte
Age
18 years and over
People
900 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07392190 · EU 2025-523659-73-00
Phase 3Taking people
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Where
Aalst, Alken, Anderlecht, Bonheiden, Edegem, Genk, Hasselt, Leuven, Liège, Mechelen, Roeselare, Thuin
Age
18 years and over
People
11,800 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT07064473 · EU 2025-521188-11-00
Phase 2Taking people
Vitamin D Supplementation to increase free testosteron in Type 2 Diabetes Mellitus men: a Placebo-controlled Randomized Clinical Trial
Where
Jette
Age
18 years and over
People
100
Run by
UZ Brussel
See details and how to join2024-514834-19-00 · EU 2024-514834-19-00
Phase 3Taking people
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Where
Alken, Kluisbergen, La Louviere, Mechelen, Roeselare, Sint-Lambrechts-Woluwe
Age
18 years and over
People
2,500 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07564414 · EU 2025-522488-14-00
Phase 3Taking people
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Where
Alken, Hasselt, Kluisbergen
Age
18 years and over
People
1,980 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07321886 · EU 2025-523657-34-00
No phaseTaking people
Evaluation of the Safety and Performance of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in People Living With Diabetes (NEXUS)
Where
Antwerp, Brussels, Leuven
Age
2 years and over
People
116 worldwide
Run by
Medtronic MiniMed, Inc.
See details and how to joinNCT07227805
Phase 3Taking people
Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes
Where
Aalst, Antwerp, Bruges, Brussels, Ieper, Kortrijk, Leuven, Liège, Mouscron, Sint-Niklaas, Turnhout
Age
18 years and over
People
252
Run by
Universitaire Ziekenhuizen KU Leuven
See details and how to joinNCT05569772 · EU 2022-502082-22-00
No phaseTaking people
Improvement Through Movement - Balance Control and Somatosensory Function in People With Diabetes Mellitus Type 2
Where
Edegem
Age
60 years and over
People
48
Run by
Universiteit Antwerpen
See details and how to joinNCT07786194
No phaseTaking people
INNODIA Family & Friends Early-Stage T1D Detection Protocol
Where
Leuven
Age
1 year to 45 years
People
30,000 worldwide
Run by
INNODIA iVZW
See details and how to joinNCT07118098
Phase 1Not yet taking people in Belgium
A first-in-human, randomized, double-blind, placebo-controlled, 3-part study assessing the safety, tolerability, pharmacodynamics and pharmacokinetics of GL0071 after single and repeated ascending subcutaneous doses in healthy normal weight, overweight and obese participants, as well as a 12-week treatment randomized, double blind, placebo-controlled exploratory Proof-of-Concept study in overweight and obese participants.
Where
Liege
Age
18 years to 64 years
People
124
Run by
Sun Pharmaceutical Industries Limited
See details and how to join2025-524233-45-00 · EU 2025-524233-45-00
No phaseTaking people
The Muscle Monitor: Early Skeletal Muscle Indicators of Insulin Resistance and Cardiometabolic Risk
Where
Ghent
Age
20 years to 30 years
People
250
Run by
University Ghent
See details and how to joinNCT07678736
No phaseTaking people
The Effect of Exercise on the Brain in Type 2 Diabetes
Where
Hasselt
Age
30 years to 75 years
People
75
Run by
Hasselt University
See details and how to joinNCT06734546
No phaseTaking people
Polyphenol Metabotypes in People With Diabetes Type 2
Where
Ghent
Age
40 years to 85 years
People
100
Run by
University Hospital, Ghent
See details and how to joinNCT06810635
Phase 2Taking people
Dapansutrile in Diabetes and Diabetes-Related Complications - Dapan-Dia
Where
Liège
Age
18 years to 75 years
People
300 worldwide
Run by
Marc Donath
See details and how to joinNCT06047262 · EU 2024-511828-14-00
No phaseEnrolling by invitation
To Evaluate the Change in Glucose Parameters in Adult Patients With Type 1 or Type 2 Diabetes From Europe Using the iCan o3 CGM System for 60 Days Period
Where
Antwerp
Age
18 years to 75 years
People
70
Run by
Sinocare
See details and how to joinNCT06904846
No phaseTaking people
A Prospective Randomnised Controlled Trial Comparing Overall Patient Compliance in a Bariatric Surgical Pathway Using the Standard Versus a More Intensified and Interactive Version of the "Get Ready" Smartphone Application.
Where
Geel
People
200
Run by
Sint Dimpna Ziekenhuis Geel
See details and how to joinNCT07297342
No phaseTaking people
Global Research Initiative for Patients Screening on MASH
Where
Antwerp, Brussels
Age
18 years to 75 years
People
10,000 worldwide
Run by
Julius Clinical
See details and how to joinNCT05651724
No phaseTaking people
24-hour Movement Behaviors Among Type 2 Diabetes Mellitus Patients
Where
Ghent
Age
18 years to 100 years
People
248
Run by
University Hospital, Ghent
See details and how to joinNCT04993482
No phaseTaking people
The European NAFLD Registry
Where
Antwerp
Age
18 years to 100 years
People
10,000 worldwide
Run by
Newcastle University
See details and how to joinNCT04442334